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In almost all lymphocytes the three members of NFAT
family of transcription factors, NFATc1, c2 and c3, are
expressed. While the nuclear transport, the DNA binding
and, therefore, the activity of all three NFATc members is
commonly controlled by the Ca2+-dependent phos-
phatase calcineurin, their transcriptional regulation dif-
fers from each other. In the majority of lymphocytes both
NFATc2 and c3 are constitutively expressed, whereas
immunoreceptor and co-receptor signals enhance rapidly
the levels of NFATc1 in effector T and B lymphocytes. This
results in the rapid synthesis of NFATc1/alphaA, a short
NFATc1 isoform, which differs mainly by the lack of a C-
terminal stretch of approximately 245 amino acid resi-
dues from other NFAT proteins. By inactivating the endog-
enous NFATc1 gene and re-introducing human NFATc1/
alphaA into chicken DT40 B cells we show here that high
NFATc1/alphaA levels protect B cells against B cell recep-
tor-mediated AICD. Prominent target genes of NFATc1/
alphaA in DT40 B cells are the Bcl-6, PKC-theta and Bag-2
genes whose expression is strongly enhanced in DT40
cells expressing human NFATc1/alphaA. The anti-apop-
totic activity of NFATc1/alphaA appears to be due to an
enhancement of NF-kappaB signals and of binding of
NFATc1 to promoters of anti-apoptotic genes. Similar to
the HIV-1 LTR and IL-8 promoters, the promoters of
numerous anti-apoptotic genes contain composite kap-
paB/NFAT sites to which NFATc1 can bind (as homodim-
ers, similar to NF-kappaB) in human NFATc1/alphaA
expressing DT40 cells. Since NFATc1/alphaA suppresses
the RNA synthesis of secreted IgM and Blimp-1 but
enhances Bcl-6 and Bach-2 RNA levels, NFATc1/alphaA
appears to control the affinity maturation of Ig genes in
germinal center (GC) B cells. Immuno-histochemical
stainings with an Ab raised against NFATc1/alpha protein
shows that – in striking contrast to the cytosolic localisa-
tion of NFATc1 in the majority of lymphoid cells –
NFATc1/alpha is constitutively expressed in nuclei of a
subset of GC B cells, as well as in Burkitt's lymphomas
which originate from GC B cells. Most of these GC B cells
expressing nuclear NFATc1/alpha do not express IgM and
apoptotic markers suggesting NFATc1/alpha contributes
to the survival of a subset of matured GC B cells. This
hypothesis is currently tested by more immunohisto-
chemical stainings and the use of genetically modified
mice carrying NFATc1 flx/flx alleles and AID- and CD23-
Cre for the inactivation of NFATc1gene in GC B cells, or
just before GC formation. All our data indicate that in T
and GC B cells the inducible synthesis of short NFATc1/
alphaA isoforms contributes to the survival of lym-
phocytes while – as we have shown earlier (see Chuvpilo
et al., Immunity 2002) – the NFATc proteins NFATc2 and
c3 support the Activation Induced Cell Death (AICD) of T
(and B) lymphocytes upon TCR (BCR) stimulation.
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